These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10486151)
1. Cultured murine parenchymal liver cells induce differentiation of bone marrow cells to macrophage-like cells which present antigen to Th1 clones but inhibit their proliferation by nitric oxide and prostaglandins. Mabuchi A; Kitajima-Shimizu M; Kikuchi K; Nakagawa Y; Takahashi H; Kakiuchi T; Yokomuro K Cell Immunol; 1999 Aug; 196(1):14-22. PubMed ID: 10486151 [TBL] [Abstract][Full Text] [Related]
2. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells. Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840 [TBL] [Abstract][Full Text] [Related]
3. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficient. van der Veen RC; Dietlin TA; Pen L; Gray JD; Hofman FM Cell Immunol; 2000 Dec; 206(2):125-35. PubMed ID: 11161444 [TBL] [Abstract][Full Text] [Related]
4. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. Roland CR; Walp L; Stack RM; Flye MW J Immunol; 1994 Dec; 153(12):5453-64. PubMed ID: 7527442 [TBL] [Abstract][Full Text] [Related]
5. Unresponsiveness of intrahepatic lymphocytes to bacterial superantigen: rapid development of suppressive Mac-1(high) cells in the mouse liver. Terabe M; Shimizu M; Mabuchi A; Matui S; Morikawa H; Kaneda K; Kakiuchi T; Yokomuro K Hepatology; 2000 Sep; 32(3):507-13. PubMed ID: 10960442 [TBL] [Abstract][Full Text] [Related]
6. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Johnson BD; Hanke CA; Becker EE; Truitt RL Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729 [TBL] [Abstract][Full Text] [Related]
7. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy. Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242 [TBL] [Abstract][Full Text] [Related]
8. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of cloned macrophage hybridomas. VII. Modulation of suppressor T cell-inducing activity. Ishikura H; Jayaraman S; Kuchroo V; Diamond B; Saito S; Dorf ME J Immunol; 1989 Jul; 143(2):414-9. PubMed ID: 2525585 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes. Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349 [TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. van der Veen RC; Dietlin TA; Dixon Gray J; Gilmore W Cell Immunol; 2000 Jan; 199(1):43-9. PubMed ID: 10675274 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of IFN-gamma production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine. Yotsumoto S; Kakiuchi T; Aramaki Y Vaccine; 2007 Jul; 25(29):5256-62. PubMed ID: 17583394 [TBL] [Abstract][Full Text] [Related]
13. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine. Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432 [TBL] [Abstract][Full Text] [Related]
14. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive phenotypic analysis of the gut intra-epithelial lymphocyte compartment: perturbations induced by acute reovirus 1/L infection of the gastrointestinal tract. Bharhani MS; Grewal JS; Peppler R; Enockson C; London L; London SD Int Immunol; 2007 Apr; 19(4):567-79. PubMed ID: 17369189 [TBL] [Abstract][Full Text] [Related]
16. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104 [TBL] [Abstract][Full Text] [Related]
17. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511 [TBL] [Abstract][Full Text] [Related]
18. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL; Antúnez MI; Abrami AA Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [TBL] [Abstract][Full Text] [Related]
19. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells. Ferret-Bernard S; Saï P; Bach JM Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293 [TBL] [Abstract][Full Text] [Related]
20. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation. Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]